 | | QSE | | Name: | all-trans okenone | | Formula: | C41 H54 O2 | | SMILES: | COC(C)(C)CCC(=O)C(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=Cc1ccc(C)c(C)c1C | | InChi: | InChI=1S/C41H54O2/c1-31(19-14-21-33(3)23-16-24-36(6)40(42)29-30-41(9,10)43-11)17-12-13-18-32(2)20-15-22-34(4)25-27-39-28-26-35(5)37(7)38(39)8/h12-28H,29-30H2,1-11H3/b13-12+,19-14+,20-15+,23-16+,27-25+,31-17+,32-18+,33-21+,34-22+,36-24+ | | Definition date: | 2020-07-31 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (6~{E},8~{E},10~{E},12~{E},14~{E},16~{E},18~{E},20~{E},22~{E},24~{E})-2-methoxy-2,6,10,14,19,23-hexamethyl-25-(2,3,4-trimethylphenyl)pentacosa-6,8,10,12,14,16,18,20,22,24-decaen-5-one |
|
 | | RQG | | Name: | (5-methyl-1-benzofuran-3-yl)acetic acid | | Formula: | C11 H10 O3 | | SMILES: | C(Cc2c1cc(C)ccc1oc2)(O)=O | | InChi: | InChI=1S/C11H10O3/c1-7-2-3-10-9(4-7)8(6-14-10)5-11(12)13/h2-4,6H,5H2,1H3,(H,12,13) | | Definition date: | 2020-02-21 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (5-methyl-1-benzofuran-3-yl)acetic acid |
|
 | | RQJ | | Name: | deoxyproclavaminic acid | | Formula: | C8 H14 N2 O3 | | SMILES: | N1(C(C(=O)O)CCCN)C(=O)CC1 | | InChi: | InChI=1S/C8H14N2O3/c9-4-1-2-6(8(12)13)10-5-3-7(10)11/h6H,1-5,9H2,(H,12,13)/t6-/m0/s1 | | Synonyms: | (2S)-5-amino-2-(2-oxoazetidin-1-yl)pentanoic acid | | Definition date: | 2020-02-21 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (2S)-5-amino-2-(2-oxoazetidin-1-yl)pentanoic acid |
|
 | | QZH | | Name: | (5~{Z})-2-[1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-5-(4-oxidanylbutylidene)-2~{H}-1,3-thiazole-4-carboxylic acid | | Formula: | C12 H17 N O6 S | | SMILES: | C[CH](O)[CH]([CH]1SC(=CCCCO)C(=N1)C(O)=O)C(O)=O | | InChi: | InChI=1S/C12H17NO6S/c1-6(15)8(11(16)17)10-13-9(12(18)19)7(20-10)4-2-3-5-14/h4,6,8,10,14-15H,2-3,5H2,1H3,(H,16,17)(H,18,19)/b7-4-/t6-,8-,10-/m1/s1 | | Definition date: | 2020-08-24 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (5~{Z})-2-[1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-5-(4-oxidanylbutylidene)-2~{H}-1,3-thiazole-4-carboxylic acid |
|
 | | EY6 | | Name: | 5-(2-fluoranylethoxy)-1H-indole | | Formula: | C10 H10 F N O | | SMILES: | FCCOc1ccc2[nH]ccc2c1 | | InChi: | InChI=1S/C10H10FNO/c11-4-6-13-9-1-2-10-8(7-9)3-5-12-10/h1-3,5,7,12H,4,6H2 | | Definition date: | 2020-02-18 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 5-(2-fluoranylethoxy)-1~{H}-indole |
|
 | | EY9 | | Name: | 5-(2-methoxyethoxy)-1H-indole | | Formula: | C11 H13 N O2 | | SMILES: | COCCOc1ccc2[nH]ccc2c1 | | InChi: | InChI=1S/C11H13NO2/c1-13-6-7-14-10-2-3-11-9(8-10)4-5-12-11/h2-5,8,12H,6-7H2,1H3 | | Definition date: | 2020-02-18 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 5-(2-methoxyethoxy)-1~{H}-indole |
|
 | | EYF | | Name: | 1-[(3-methoxyphenyl)methyl]-~{N}-oxidanyl-pyrrolo[2,3-b]pyridine-5-carboxamide | | Formula: | C16 H15 N3 O3 | | SMILES: | COc1cccc(Cn2ccc3cc(cnc23)C(=O)NO)c1 | | InChi: | InChI=1S/C16H15N3O3/c1-22-14-4-2-3-11(7-14)10-19-6-5-12-8-13(16(20)18-21)9-17-15(12)19/h2-9,21H,10H2,1H3,(H,18,20) | | Definition date: | 2020-02-19 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 1-[(3-methoxyphenyl)methyl]-~{N}-oxidanyl-pyrrolo[2,3-b]pyridine-5-carboxamide |
|
 | | EYL | | Name: | ~{N}-oxidanyl-1-(phenylmethyl)pyrrolo[2,3-b]pyridine-4-carboxamide | | Formula: | C15 H13 N3 O2 | | SMILES: | ONC(=O)c1ccnc2n(Cc3ccccc3)ccc12 | | InChi: | InChI=1S/C15H13N3O2/c19-15(17-20)13-6-8-16-14-12(13)7-9-18(14)10-11-4-2-1-3-5-11/h1-9,20H,10H2,(H,17,19) | | Definition date: | 2020-02-19 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | ~{N}-oxidanyl-1-(phenylmethyl)pyrrolo[2,3-b]pyridine-4-carboxamide |
|
 | | EZU | | Name: | 1-cyclopentyl-6-[[(2R)-1-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-1-oxidanylidene-propan-2-yl]amino]-5H-pyrazolo[3,4-d]pyrimidin-4-one | | Formula: | C18 H24 N6 O3 | | SMILES: | C[CH](NC1=Nc2n(ncc2C(=O)N1)C3CCCC3)C(=O)N4CC5(COC5)C4 | | InChi: | InChI=1S/C18H24N6O3/c1-11(16(26)23-7-18(8-23)9-27-10-18)20-17-21-14-13(15(25)22-17)6-19-24(14)12-4-2-3-5-12/h6,11-12H,2-5,7-10H2,1H3,(H2,20,21,22,25)/t11-/m1/s1 | | Definition date: | 2020-02-28 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | 1-cyclopentyl-6-[[(2~{R})-1-(2-oxa-6-azaspiro[3.3]heptan-6-yl)-1-oxidanylidene-propan-2-yl]amino]-5~{H}-pyrazolo[3,4-d]pyrimidin-4-one |
|
 | | GV6 | | Name: | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2S,3S)-2-azanyl-3-methyl-pentanoate | | Formula: | C16 H25 N6 O8 P | | SMILES: | CC[CH](C)[CH](N)C(=O)O[P](O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23 | | InChi: | InChI=1S/C16H25N6O8P/c1-3-7(2)9(17)16(25)30-31(26,27)28-4-8-11(23)12(24)15(29-8)22-6-21-10-13(18)19-5-20-14(10)22/h5-9,11-12,15,23-24H,3-4,17H2,1-2H3,(H,26,27)(H2,18,19,20)/t7-,8+,9-,11+,12+,15+/m0/s1 | | Definition date: | 2020-09-29 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] (2~{S},3~{S})-2-azanyl-3-methyl-pentanoate |
|
 | | GVU | | Name: | (2E,4S,5S,6E,8E)-10-[(2S,3R,6S,8R,9S)-3-butyl-9-methyl-2-[(1E,3E)-3-methyl-5-oxidanyl-5-oxidanylidene-penta-1,3-dienyl]-3-(4-oxidanyl-4-oxidanylidene-butanoyl)oxy-1,7-dioxaspiro[5.5]undecan-8-yl]-4,8-dimethyl-5-oxidanyl-deca-2,6,8-trienoic acid | | Formula: | C36 H52 O11 | | SMILES: | CCCC[C]1(CC[C]2(CC[CH](C)[CH](CC=C(C)C=C[CH](O)[CH](C)C=CC(O)=O)O2)O[CH]1C=CC(C)=CC(O)=O)OC(=O)CCC(O)=O | | InChi: | InChI=1S/C36H52O11/c1-6-7-19-35(47-34(44)17-16-32(40)41)21-22-36(46-30(35)14-10-25(3)23-33(42)43)20-18-27(5)29(45-36)13-9-24(2)8-12-28(37)26(4)11-15-31(38)39/h8-12,14-15,23,26-30,37H,6-7,13,16-22H2,1-5H3,(H,38,39)(H,40,41)(H,42,43)/b12-8+,14-10+,15-11+,24-9+,25-23+/t26-,27-,28-,29+,30-,35+,36-/m0/s1 | | Definition date: | 2020-09-29 | | Last modified: | 2021-02-19 | | Release date: | 2021-02-24 | | Identifier: | (2~{E},4~{S},5~{S},6~{E},8~{E})-10-[(2~{S},3~{R},6~{S},8~{R},9~{S})-3-butyl-9-methyl-2-[(1~{E},3~{E})-3-methyl-5-oxidanyl-5-oxidanylidene-penta-1,3-dienyl]-3-(4-oxidanyl-4-oxidanylidene-butanoyl)oxy-1,7-dioxaspiro[5.5]undecan-8-yl]-4,8-dimethyl-5-oxidanyl-deca-2,6,8-trienoic acid |
|
 | | F05 | | Name: | 1H-isoindol-3-amine | | Formula: | C8 H8 N2 | | SMILES: | c1cccc2c1cnc2N | | InChi: | InChI=1S/C8H8N2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4H,5H2,(H2,9,10) | | Definition date: | 2010-11-15 | | Last modified: | 2021-02-16 | | Identifier: | 2H-isoindol-1-amine |
|
 | | O5Z | | Name: | (2~{S})-1-[(2~{R})-2-azanyl-3-phenyl-propanoyl]-~{N}-[(5-bromanylfuran-2-yl)methyl]pyrrolidine-2-carboxamide | | Formula: | C19 H22 Br N3 O3 | | SMILES: | N[CH](Cc1ccccc1)C(=O)N2CCC[CH]2C(=O)NCc3oc(Br)cc3 | | InChi: | InChI=1S/C19H22BrN3O3/c20-17-9-8-14(26-17)12-22-18(24)16-7-4-10-23(16)19(25)15(21)11-13-5-2-1-3-6-13/h1-3,5-6,8-9,15-16H,4,7,10-12,21H2,(H,22,24)/t15-,16+/m1/s1 | | Definition date: | 2020-02-10 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | (2~{S})-1-[(2~{R})-2-azanyl-3-phenyl-propanoyl]-~{N}-[(5-bromanylfuran-2-yl)methyl]pyrrolidine-2-carboxamide |
|
 | | XYJ | | Name: | 3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide | | Formula: | C16 H24 N6 O6 S2 | | SMILES: | C(NS(CCN1CCOCC1)(=O)=O)(CCSc3nc2c(C(N(C(N2C)=O)C)=O)n3)=O | | InChi: | InChI=1S/C16H24N6O6S2/c1-20-13-12(14(24)21(2)16(20)25)17-15(18-13)29-9-3-11(23)19-30(26,27)10-6-22-4-7-28-8-5-22/h3-10H2,1-2H3,(H,17,18)(H,19,23) | | Definition date: | 2021-01-20 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide |
|
 | | RV2 | | Name: | 5-Chloro-2-[[2-[3-(furan-3-yl)anilino]-2-oxoacetyl]amino]benzoic acid | | Formula: | C19 H13 Cl N2 O5 | | SMILES: | OC(=O)c1cc(Cl)ccc1NC(=O)C(=O)Nc2cccc(c2)c3cocc3 | | InChi: | InChI=1S/C19H13ClN2O5/c20-13-4-5-16(15(9-13)19(25)26)22-18(24)17(23)21-14-3-1-2-11(8-14)12-6-7-27-10-12/h1-10H,(H,21,23)(H,22,24)(H,25,26) | | Synonyms: | 5-chloranyl-2-[[2-[[3-(furan-3-yl)phenyl]amino]-2-oxidanylidene-ethanoyl]amino]benzoic acid | | Definition date: | 2020-10-21 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 5-chloranyl-2-[[2-[[3-(furan-3-yl)phenyl]amino]-2-oxidanylidene-ethanoyl]amino]benzoic acid |
|
 | | XZS | | Name: | N-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-2-methylpropane-2-sulfonamide | | Formula: | C27 H33 F3 N6 O2 S | | SMILES: | c2c(cc(c(C1CCN(CC1)C)c2F)F)Nc3nc(c(C)cn3)Nc4ccc(F)c(NS(C(C)(C)C)(=O)=O)c4 | | InChi: | InChI=1S/C27H33F3N6O2S/c1-16-15-31-26(33-19-12-21(29)24(22(30)13-19)17-8-10-36(5)11-9-17)34-25(16)32-18-6-7-20(28)23(14-18)35-39(37,38)27(2,3)4/h6-7,12-15,17,35H,8-11H2,1-5H3,(H2,31,32,33,34) | | Definition date: | 2021-01-22 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-2-methylpropane-2-sulfonamide |
|
 | | XZV | | Name: | 4-(5-chlorofuran-2-carbonyl)-N-(cyclopropylmethyl)piperazine-1-carboxamide | | Formula: | C14 H18 Cl N3 O3 | | SMILES: | N2(CCN(C(c1ccc(Cl)o1)=O)CC2)C(NCC3CC3)=O | | InChi: | InChI=1S/C14H18ClN3O3/c15-12-4-3-11(21-12)13(19)17-5-7-18(8-6-17)14(20)16-9-10-1-2-10/h3-4,10H,1-2,5-9H2,(H,16,20) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(5-chlorofuran-2-carbonyl)-N-(cyclopropylmethyl)piperazine-1-carboxamide |
|
 | | XZY | | Name: | 4-(5-chlorofuran-2-carbonyl)-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide | | Formula: | C12 H13 Cl F3 N3 O3 | | SMILES: | N(CC(F)(F)F)C(N2CCN(C(=O)c1ccc(Cl)o1)CC2)=O | | InChi: | InChI=1S/C12H13ClF3N3O3/c13-9-2-1-8(22-9)10(20)18-3-5-19(6-4-18)11(21)17-7-12(14,15)16/h1-2H,3-7H2,(H,17,21) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(5-chlorofuran-2-carbonyl)-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide |
|
 | | Y0A | | Name: | N-butyl-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C14 H21 N3 O3 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(NCCCC)=O | | InChi: | InChI=1S/C14H21N3O3/c1-2-3-6-15-14(19)17-9-7-16(8-10-17)13(18)12-5-4-11-20-12/h4-5,11H,2-3,6-10H2,1H3,(H,15,19) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-butyl-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0D | | Name: | N-(cyclopropylmethyl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide | | Formula: | C14 H19 N3 O2 S | | SMILES: | N(CC1CC1)C(N3CCN(C(=O)c2cccs2)CC3)=O | | InChi: | InChI=1S/C14H19N3O2S/c18-13(12-2-1-9-20-12)16-5-7-17(8-6-16)14(19)15-10-11-3-4-11/h1-2,9,11H,3-8,10H2,(H,15,19) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(cyclopropylmethyl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0G | | Name: | N-(2-fluoro-4-methoxyphenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C17 H18 F N3 O4 | | SMILES: | N2(C(=O)Nc1ccc(OC)cc1F)CCN(CC2)C(c3occc3)=O | | InChi: | InChI=1S/C17H18FN3O4/c1-24-12-4-5-14(13(18)11-12)19-17(23)21-8-6-20(7-9-21)16(22)15-3-2-10-25-15/h2-5,10-11H,6-9H2,1H3,(H,19,23) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(2-fluoro-4-methoxyphenyl)-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0J | | Name: | N-(1,3-benzoxazol-2-yl)-4-(furan-2-carbonyl)piperazine-1-carboxamide | | Formula: | C17 H16 N4 O4 | | SMILES: | n2c1c(cccc1)oc2NC(N4CCN(C(=O)c3ccco3)CC4)=O | | InChi: | InChI=1S/C17H16N4O4/c22-15(14-6-3-11-24-14)20-7-9-21(10-8-20)17(23)19-16-18-12-4-1-2-5-13(12)25-16/h1-6,11H,7-10H2,(H,18,19,23) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | N-(1,3-benzoxazol-2-yl)-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
 | | Y0Y | | Name: | 4-(furan-2-carbonyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide | | Formula: | C17 H19 N3 O4 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(Nc3ccc(OC)cc3)=O | | InChi: | InChI=1S/C17H19N3O4/c1-23-14-6-4-13(5-7-14)18-17(22)20-10-8-19(9-11-20)16(21)15-3-2-12-24-15/h2-7,12H,8-11H2,1H3,(H,18,22) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(furan-2-carbonyl)-N-(4-methoxyphenyl)piperazine-1-carboxamide |
|
 | | Y1A | | Name: | 4-(furan-2-carbonyl)-N-(propan-2-yl)piperazine-1-carboxamide | | Formula: | C13 H19 N3 O3 | | SMILES: | N2(CCN(C(=O)c1ccco1)CC2)C(NC(C)C)=O | | InChi: | InChI=1S/C13H19N3O3/c1-10(2)14-13(18)16-7-5-15(6-8-16)12(17)11-4-3-9-19-11/h3-4,9-10H,5-8H2,1-2H3,(H,14,18) | | Definition date: | 2021-01-25 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 4-(furan-2-carbonyl)-N-(propan-2-yl)piperazine-1-carboxamide |
|
 | | V5S | | Name: | 2-[(4-bromophenyl)amino]ethan-1-ol | | Formula: | C8 H10 Br N O | | SMILES: | N(CCO)c1ccc(Br)cc1 | | InChi: | InChI=1S/C8H10BrNO/c9-7-1-3-8(4-2-7)10-5-6-11/h1-4,10-11H,5-6H2 | | Definition date: | 2020-06-30 | | Last modified: | 2021-02-12 | | Release date: | 2021-02-17 | | Identifier: | 2-[(4-bromophenyl)amino]ethan-1-ol |
|